CIK 0001561921 · Non-accelerated filer<br>Smaller reporting company
TELA Bio, Inc.
Sign in to watch- Ticker
- TELA
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 455320061
- Phone
- 484-320-2930
- Business address
- 1 GREAT VALLEY PARKWAY, SUITE 24, MALVERN, PA, 19355
- Open-market buys, last 90 days
- $175,549
- in 3 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$175,549. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-06-01 | Azarbarzin Kurt Director | Grant or award · Stock Option (Right to Buy) | +5,360 | 5,360 | ||
| 2023-06-01 | Nosenzo John Director | Grant or award | +3,135 | 6,270 | ||
| 2023-06-01 | Nosenzo John Director | Grant or award · Stock Option (Right to Buy) | +5,360 | 5,360 | ||
| 2023-06-01 | Burgess Vincent J Director | Grant or award | +3,135 | 11,130 | ||
| 2023-06-01 | Burgess Vincent J Director | Grant or award · Stock Option (Right to Buy) | +5,360 | 5,360 | ||
| 2023-04-21 | ORBIMED ADVISORS LLC 10% owner | Sale | −27,700 | $9.41 | $261K | 2,835,542 |
| 2023-04-20 | ORBIMED ADVISORS LLC 10% owner | Sale | −28,300 | $9.43 | $267K | 2,863,242 |
| 2023-04-19 | ORBIMED ADVISORS LLC 10% owner | Sale | −136,000 | $9.30 | $1.3M | 2,891,542 |
| 2023-03-31 | KOBLISH ANTONY Chief Executive Officer | Shares withheld for taxes | −385 | $10.64 | $4K | 292,634 |
| 2023-03-31 | Smeykal Megan Chief Accounting Officer | Shares withheld for taxes | −96 | $10.64 | $1K | 20,431 |
| 2023-03-31 | Murphy Peter C. Chief Commercial Officer | Shares withheld for taxes | −163 | $10.64 | $2K | 37,987 |
| 2023-03-31 | Talmo Paul Chief Strategic Officer | Shares withheld for taxes | −187 | $10.64 | $2K | 55,976 |
| 2023-03-29 | Burgess Vincent J Director | Option exercise | +4,860 | $4.44 | $22K | 7,995 |
| 2023-03-29 | Burgess Vincent J Director | Option exercise · Stock Option (Right to Buy) | −4,860 | 0 | ||
| 2023-02-24 | Murphy Peter C. Chief Commercial Officer | Shares withheld for taxes | −940 | $11.03 | $10K | 38,150 |
| 2023-02-24 | Talmo Paul Chief Strategic Officer | Shares withheld for taxes | −1,032 | $11.03 | $11K | 56,163 |
| 2023-02-24 | KOBLISH ANTONY Chief Executive Officer | Shares withheld for taxes | −6,034 | $11.03 | $67K | 293,019 |
| 2023-02-24 | Smeykal Megan Chief Accounting Officer | Shares withheld for taxes | −539 | $11.03 | $6K | 20,527 |
| 2023-02-23 | Cuca Roberto COO and CFO | Grant or award | +17,700 | 52,592 | ||
| 2023-02-23 | Cuca Roberto COO and CFO | Shares withheld for taxes | −1,300 | $10.50 | $14K | 51,292 |
Page 9 of 12 · 237 trades